SERPINE1 and urinary bladder carcinoma: intravesically injected a high concentration of plasminogen activator inhibitor-1 (PAI-1) into the bladder of a rat bladder model, resulting in a 53% reduction in tumor size and a decrease in muscular invasion, which suggesting the potential of uPA as a therapeutic target for bladder cancer (46).